These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 23484796

  • 1. Dabigatran and postmarketing reports of bleeding.
    Southworth MR, Reichman ME, Unger EF.
    N Engl J Med; 2013 Apr 04; 368(14):1272-4. PubMed ID: 23484796
    [No Abstract] [Full Text] [Related]

  • 2. A comparison of results of the US food and drug administration's mini-sentinel program with randomized clinical trials: the case of gastrointestinal tract bleeding with dabigatran.
    Sipahi I, Celik S, Tozun N.
    JAMA Intern Med; 2014 Jan 04; 174(1):150-1. PubMed ID: 24247291
    [No Abstract] [Full Text] [Related]

  • 3. Dabigatran, bleeding, and the regulators.
    Moore TJ, Cohen MR, Mattison DR.
    BMJ; 2014 Jul 23; 349():g4517. PubMed ID: 25056265
    [No Abstract] [Full Text] [Related]

  • 4. Is there really misuse and abuse of dabigatran?
    Eikelboom JW, Hankey GJ.
    Med J Aust; 2013 Apr 15; 198(7):358-9. PubMed ID: 23581946
    [No Abstract] [Full Text] [Related]

  • 5. The trouble with dabigatran.
    Charlton B, Redberg R.
    BMJ; 2014 Jul 23; 349():g4681. PubMed ID: 25055830
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Bleeding rates in Veterans Affairs patients with atrial fibrillation who switch from warfarin to dabigatran.
    Vaughan Sarrazin MS, Jones M, Mazur A, Chrischilles E, Cram P.
    Am J Med; 2014 Dec 23; 127(12):1179-85. PubMed ID: 25107386
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of dabigatran bleeding adverse reaction reports in the FDA adverse event reporting system during the first year of approval.
    McConeghy KW, Bress A, Qato DM, Wing C, Nutescu EA.
    Pharmacotherapy; 2014 Jun 23; 34(6):561-9. PubMed ID: 24644100
    [Abstract] [Full Text] [Related]

  • 10. Risk of bleeding with dabigatran in atrial fibrillation.
    Hernandez I, Baik SH, Piñera A, Zhang Y.
    JAMA Intern Med; 2015 Jan 23; 175(1):18-24. PubMed ID: 25365537
    [Abstract] [Full Text] [Related]

  • 11. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.
    Graham DJ, Reichman ME, Wernecke M, Zhang R, Southworth MR, Levenson M, Sheu TC, Mott K, Goulding MR, Houstoun M, MaCurdy TE, Worrall C, Kelman JA.
    Circulation; 2015 Jan 13; 131(2):157-64. PubMed ID: 25359164
    [Abstract] [Full Text] [Related]

  • 12. Bleeding risk with dabigatran in the frail elderly.
    Harper P, Young L, Merriman E.
    N Engl J Med; 2012 Mar 01; 366(9):864-6. PubMed ID: 22375994
    [No Abstract] [Full Text] [Related]

  • 13. [Dabigatran and risk of bleeding].
    Hasler S.
    Praxis (Bern 1994); 2015 Jan 28; 104(3):157-8. PubMed ID: 25626386
    [No Abstract] [Full Text] [Related]

  • 14. Risk of Bleeding With Dabigatran in 2010-2011 Medicare Data.
    Hernandez I, Zhang Y.
    JAMA Intern Med; 2015 Jul 28; 175(7):1245-7. PubMed ID: 26146922
    [No Abstract] [Full Text] [Related]

  • 15. Atrial fibrillation: Risk of bleeding with dabigatran versus warfarin particularly high in CKD.
    Carney EF.
    Nat Rev Nephrol; 2015 Jan 28; 11(1):3. PubMed ID: 25421829
    [No Abstract] [Full Text] [Related]

  • 16. [New anticoagulants, new emergencies?].
    Djalali S.
    Praxis (Bern 1994); 2013 Jul 24; 102(15):945-6. PubMed ID: 23876694
    [No Abstract] [Full Text] [Related]

  • 17. Gastrointestinal bleeding. Gastrointestinal bleeding risk is increased by novel anticoagulants.
    Rockey DC.
    Nat Rev Gastroenterol Hepatol; 2015 Mar 24; 12(3):131-2. PubMed ID: 25601661
    [Abstract] [Full Text] [Related]

  • 18. Patient Characteristics and Risk of Bleeding With Dabigatran in Atrial Fibrillation.
    Henriksen DP, Hansen MR, Damkier P.
    JAMA Intern Med; 2015 Jul 24; 175(7):1245. PubMed ID: 26146921
    [No Abstract] [Full Text] [Related]

  • 19. Dosage of Dabigatran as a Risk Factor for Bleeding in Atrial Fibrillation.
    Liu S, Kim CO, Lucyk SN.
    JAMA Intern Med; 2015 Jul 24; 175(7):1244-5. PubMed ID: 26146920
    [No Abstract] [Full Text] [Related]

  • 20. The Role of Selection in the Risk of Bleeding With Dabigatran in Patients With Atrial Fibrillation.
    Klil-Drori A, Azoulay L.
    JAMA Intern Med; 2015 Jul 24; 175(7):1243-4. PubMed ID: 26146918
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.